Ensifentrine

CHEMBL4594287 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
477.6 g/mol
LogP
2.7
Phase
4

This inhaled medication relaxes airway muscles and reduces airway inflammation by blocking two different enzymes involved in bronchoconstriction. It is used to improve breathing in adults with chronic obstructive pulmonary disease.

Peso molecular

477,6000 g/mol

LogP

2,70

TPSA

109,00 Ų

Regla de cinco de Lipinski

Cumple

Áreas terapéuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COc1cc2c(cc1OC)-c1c/c(=N\c3c(C)cc(C)cc3C)n(CCNC(N)=O)c(=O)n1CC2

InChI

InChI=1S/C26H31N5O4/c1-15-10-16(2)24(17(3)11-15)29-23-14-20-19-13-22(35-5)21(34-4)12-18(19)6-8-30(20)26(33)31(23)9-7-28-25(27)32/h10-14H,6-9H2,1-5H3,(H3,27,28,32)/b29-23+

Molecular Formula

C26H31N5O4

HBD / HBA

2 / 5

Enlaces Rotables

6

Átomos Pesados

35

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

This inhaled medication relaxes airway muscles and reduces airway inflammation by blocking two different enzymes involved in bronchoconstriction. It is used to improve breathing in adults with chronic obstructive pulmonary disease.

Yes, Ensifentrine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4594287. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 9934746. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.